More Layoffs Loom As M&A Zooms

The pace of layoffs in biopharma may be the same as it was a year ago, but it is expected to pick up in the coming months. Biopharmas are already in consolidation mode, and they will cut jobs and curtail operations more and more as they struggle to recoup the costs of associated with a wave of mergers and acquisitions.

Between January and July of this year, pharmaceutical employers announced the elimination of 6,334 jobs—up 1% from the same period in 2014, according to the latest monthly Job-Cut Announcement Report by Challenger, Gray & Christmas, released August 6.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC